The antibody or antibody fragment according to claim 1, wherein said antibody or antibody fragment is selected from the group consisting of a monoclonal antibody, a chimeric antibody, a humanized ...

Novel small antibody fragment: ... Antibodies recognize a specific antigen unique to its target as they possess the antigen-binding sites located at the upper tips of the Y.

We present a bispecific antibody that recognizes an antigen and a hapten and can be applied to various biological assays, including immunoblotting and immunoprecipitation. In immunoblot analysis ...

Numab’s preclinical-stage anti-tumor necrosis factor (TNF) antibody fragment ND009 is in development against inflammatory bowel disease and is licensed to Tillotts Pharma.

Concentrations of the antibody fragment in the vitreous samples were estimated to be 50–150 ng/ml at 12 h. Penetration of the parental whole antibody into the vitreous was not observed.